Semaglutide may protect Kidneys in Overweight Patients with Heart Disease, Study finds Anshika Mishra28 May 2024 8:00 AM ISTIn a groundbreaking study published in the New England Journal of Medicine, researchers discovered that semaglutide significantly reduces risk of...
Semaglutide reduces risk of major kidney events and death from CV causes among diabetes patients with CKD: NEJM Dr Kartikeya Kohli27 May 2024 8:15 PM ISTThe FLOW (Evaluate Renal Function with Semaglutide Once Weekly) study is a double-blind, randomised, placebo-controlled international trial comprising...
Dupilumab lowers exacerbations in COPD and type 2 inflammation and improves lung function: NEJM Dr. Kamal Kant Kohli25 May 2024 8:15 AM ISTChronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug-dupilumab-that showed rapid and sustained...
NEJM study reveals Link between COVID-19 vaccine complication and rare 'common cold' blood disease Dr. Kamal Kant Kohli17 May 2024 7:15 AM ISTNew research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis...
Thrombectomy promising for Stroke with Large Infarct of Unrestricted Size, unravels study Medha Baranwal14 May 2024 7:30 AM ISTFrance: In medical breakthroughs, the recent trial focusing on thrombectomy for stroke with a large infarct of unrestricted size has ignited hope...
FDA approves dissolving stent for endovascular treatment of peripheral artery disease below knee Dr. Kamal Kant Kohli2 May 2024 8:45 AM ISTThe US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the...
FFR-guided complete revascularization fails to improve outcomes in patients with MI: NEJM Medha Baranwal25 April 2024 10:00 AM ISTSweden: Fractional flow reserve (FFR)-guided complete revascularization does not result in better outcomes compared with primary percutaneous coronary...
Revascularization enhances quality of life for patients with chronic limb threatening ischemia: NEJM Dr. Kamal Kant Kohli11 April 2024 6:30 PM ISTResearchers have found in a new study that revascularization may restores sufficient blood flow back into the legs and significantly improves...
Beta-blocker use after MI and preserved ejection fraction offers no benefit: REDUCE-AMI trial Medha Baranwal10 April 2024 9:30 PM ISTSweden: Findings from the REDUCE-AMI published in The New England Journal of Medicine have shown no benefit of beta-blockers in revascularized...
Experimental drug Olezarsen may reduce hypertriglyceridemia in high-risk patients: NEJM Dr. Kamal Kant Kohli10 April 2024 8:45 AM ISTHypertriglyceridemia, or high levels of lipids (fats) in the blood, increases the risk of heart attack, stroke and acute pancreatitis. Currently...
Empagliflozin fails to reduce HF hospitalizations, deaths after acute MI: EMPACT-MI Medha Baranwal9 April 2024 10:00 AM ISTUSA: Treatment with empagliflozin did not lead to a significantly reduced risk of first hospitalization for heart failure (HF) or death from any cause...
Primary care strategy did not reduce hospitalizations at one year in kidney-dysfunction triad: ICD-Pieces study Dr Kartikeya Kohli5 April 2024 2:00 AM ISTUSA: Using an electronic health record (EHR)-based algorithm plus practice facilitators embedded in primary care clinics did not reduce...
